273 related articles for article (PubMed ID: 3247626)
21. Acute myeloblastic leukemia in adults.
Kasthuri AS; Jaiprakash MP; Anand KP; Kumar R
J Assoc Physicians India; 1995 Feb; 43(2):108-10. PubMed ID: 9282674
[No Abstract] [Full Text] [Related]
22. [Late results of the treatment of acute granulocytic leukemia in adults].
Perilov AA; Volkova MA; Frenkel' MA
Ter Arkh; 1989; 61(7):8-11. PubMed ID: 2588148
[TBL] [Abstract][Full Text] [Related]
23. Influence of daunorubicin and cytarabine sequencing on the outcome of therapy in acute myelogenous leukemia: a randomized trial.
Archimbaud E; Fiere D; Treille-Ritouet D; Adeleine P; Guyotat D; Sebban C; Vuvan H; Viala JJ
Cancer Treat Rep; 1987 Jun; 71(6):571-4. PubMed ID: 3555788
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of acute myeloblastic leukemia with daunorubicin and cytosine-arabinoside].
Thorling K; Petersen HS; Jensen KB; Bastrup-Madsen P
Ugeskr Laeger; 1972 Oct; 134(42):2201-5. PubMed ID: 4507751
[No Abstract] [Full Text] [Related]
25. [Intermediate-dose cytosine arabinoside therapy in refractory acute leukemia].
Ohshima A; Yoshida K; Miyazaki S; Fukushima Y; Miura AB; Endo K; Ando H; Sasaki H; Saito S; Sato I
Gan To Kagaku Ryoho; 1989 Jan; 16(1):139-42. PubMed ID: 2643393
[No Abstract] [Full Text] [Related]
26. [Results of the treatment of lymphoblastic leukemia by the BFM program in children--a 5-year observation].
Rokicka-Milewska R; Derulska D; Makowska K; Skwarska E; Lewicki Z
Acta Haematol Pol; 1987; 18(1-2):1-8. PubMed ID: 3481150
[No Abstract] [Full Text] [Related]
27. The childhood AML studies BFM-78 and -83: treatment results and risk factor analysis.
Creutzig U; Ritter J; Riehm H; Budde M; Schellong G
Haematol Blood Transfus; 1987; 30():71-5. PubMed ID: 3305225
[No Abstract] [Full Text] [Related]
28. [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside].
Patterson D; Kravtsova VM; Petrova EM; Zabelina TS; Balaian LN
Ter Arkh; 1987; 59(12):81-6. PubMed ID: 3482131
[TBL] [Abstract][Full Text] [Related]
29. Progress in acute myelogenous leukemia.
Gale RP
Cancer Treat Rep; 1981; 65 Suppl 4():87-92. PubMed ID: 7049383
[TBL] [Abstract][Full Text] [Related]
30. Vincristine (NSC-67574), cytosine arabinoside (NSC-63878), 6 thioguanine (NSC-752) and daunorubicin (NSC-82151) (VAT-D): a pilot study of combination chemotherapy for remission induction in acute myeloid leukemia in adults.
Sartiano GP; Pfrimmer WJ; Turner AR
Med Pediatr Oncol; 1978; 4(3):205-12. PubMed ID: 277748
[TBL] [Abstract][Full Text] [Related]
31. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
Ochocka M; Zelenay E
Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658
[No Abstract] [Full Text] [Related]
32. Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study.
Rees JK; Gray RG
Haematol Blood Transfus; 1990; 33():243-8. PubMed ID: 1691131
[No Abstract] [Full Text] [Related]
33. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of the therapeutic efficacy and prognostic factors of intensive chemotherapy in 91 patients with acute nonlymphoblastic leukemia].
Bian SG; Hao YS; Wang ZC
Zhonghua Nei Ke Za Zhi; 1990 Jan; 29(1):22-5, 60. PubMed ID: 2401166
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic results in acute myelogenous leukemia in the years from 1970 to 1982].
Kurrle E; Hoelzer D; Heimpel H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):698-709. PubMed ID: 2416646
[TBL] [Abstract][Full Text] [Related]
36. Acute myeloid leukemia in adults: experience at AIIMS.
Raina V; Kochupillai V
J Assoc Physicians India; 1983 Aug; 31(8):511-4. PubMed ID: 6581155
[No Abstract] [Full Text] [Related]
37. Acute granulocytic leukemia in adults.
Frei E
N Engl J Med; 1972 Jun; 286(22):1211-2. PubMed ID: 4502491
[No Abstract] [Full Text] [Related]
38. [Possibilities for the cure of acute myeloblastic leukemia with the modified VAPA regimen: preliminary results].
Díaz Mediavilla J; del Potro Gómez E; Llorente Pérez L; Martínez Martínez R; Guerra Moyano JL; de la Vega Bueno E; Alvarez Carmona A; Krsnik Castelló I; Alarcón Zurita C; Rodríguez Vázquez M
Med Clin (Barc); 1984 Dec; 83(19):783-6. PubMed ID: 6597329
[No Abstract] [Full Text] [Related]
39. [A case of refractory acute myeloblastic leukemia who achieved partial remission by high dose cytosine arabinoside].
Okamoto S; Ogata H; Yoshida T; Oheda Y; Murase T; Toyama K
Rinsho Ketsueki; 1984 May; 25(5):719-23. PubMed ID: 6590900
[No Abstract] [Full Text] [Related]
40. Consolidation therapy without maintenance for acute non-lymphoblastic leukaemia.
Roberts MM; Juttner CA; Blunden RW; Horvath N; To LB; Ho JQ; Dart GW; Kimber RJ
Med J Aust; 1988 Feb; 148(4):181-3. PubMed ID: 3340044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
